CVE-2026-0856
Improper Access Control vulnerability in Mesalvo MEONA (MEONA Client and MEONA Server) allows an authenticated MEONA user to access administrative functions of the MEONA Client (admin panel). The MEONA Server does not independently verify the role asserted by the MEONA Client. A user who holds a valid MEONA user account and is able to execute a modified copy of the MEONA Client on a device within the operating hospital's network can assert an administrator role and access administrative functions with regular user credentials. Exploitation requires: (1) a valid MEONA user account issued by the operating hospital; (2) network access to the MEONA Server, which is operated exclusively within closed hospital networks without exposure to the public Internet (where a hospital permits remote access to that network at all, it is only through the hospital's own remote-access infrastructure (e.g. VPN) under the hospital's control); (3) the ability to modify MEONA Client binaries and to execute the modified copy on a device in that network. On managed devices with application control, as recommended in Mesalvo's hardening guidance (MSA-2026-001), this requires local administrator privileges on the device. Mesalvo is not aware of any exploitation outside the reported security test. This issue affects MEONA Client and MEONA Server in versions 2024.10, 2025.04 and 2026.03. Mitigations are available with MEONA 2025.04.24 and 2026.03.02 (planned Q4 2026); see Mesalvo Security Advisory MSA-2026-001.
Executive briefing
A structured intelligence assessment has not yet been generated. The source description is shown above. The background enrichment worker will retry this record.
Evidence confidence: Not assessed Evidence-derived, not an exploitability verdict
Severity & attack characteristics
CVSS vector:CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
No CVSS vector is currently available in the source record.
Technical explanation & impact
Technical root-cause details are not available in the current source record.
Assess the impact using the published CVSS metrics and the affected vendor component.
Affected products and versions
NVD has not supplied machine-readable vulnerable CPE product/version entries for this CVE. This is an information gap, not proof that no products are affected. Check the vendor advisory references below.
Remediation & validation
- Identify exposure by comparing the affected product and version ranges with your asset inventory, SBOM and externally exposed services.
- Review the linked vendor security advisory or patch notes. Upgrade to a vendor-confirmed fixed release; do not infer a fixed version from the CVE description.
- Until patched, consider restricting network access or disabling the affected feature where operationally safe. These are temporary controls, not a substitute for a vendor fix.
- Validate the remediation with a version check and vulnerability rescan, then retain change evidence.
No fixed version is displayed unless it is explicitly established by a vendor advisory. Follow the vendor's release notes for exact product and branch applicability.